title: Facial hyperpigmentation during imatinib therapy for gastrointestinal stromal tumor.
abstract: We report a rare case of facial hyperpigmentation during imatinib therapy for a gastrointestinal stromal tumor.
authors.affiliation: Centre national de Pharmacovigilance de Tunis, Tunisie.
authors.forename: Imene
authors.initials: I
authors.lastname: Hamza
authors.affiliation: Centre national de Pharmacovigilance de Tunis, Tunisie - Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis, Tunisie.
authors.forename: Emna
authors.initials: E
authors.lastname: Gaies
authors.affiliation: Centre national de Pharmacovigilance de Tunis, Tunisie - Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis, Tunisie.
authors.forename: Sarrah
authors.initials: S
authors.lastname: Kastalli
authors.affiliation: Centre national de Pharmacovigilance de Tunis, Tunisie - Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis, Tunisie.
authors.forename: Riadh
authors.initials: R
authors.lastname: Daghfous
authors.affiliation: Centre national de Pharmacovigilance de Tunis, Tunisie - Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis, Tunisie.
authors.forename: Sihem
authors.initials: S
authors.lastname: El Aidli
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001549:Benzamides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005148:Facial Dermatoses / Q000139:chemically induced*; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy / Q000473:pathology; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate